ADMA Biologics Inc vs Byrna Technologies Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Byrna Technologies Inc trades at $4.68 (market cap $106.74M). The key difference: ADMA Biologics Inc is far larger — about 20.8× Byrna Technologies Inc's market cap, and ADMA Biologics Inc is trading nearer its 52-week high, Byrna Technologies Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | BYRN | |
|---|---|---|
Market Cap | $2.22B | $106.74M |
Sector | Health | Technology |
52-Week High | $20.38 | $27.63 |
52-Week Low | $7.60 | $3.18 |
Enterprise Value | $2.29B | $98.35M |
Trailing returns across standard periods
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →Byrna Technologies specializes in less-lethal personal security devices. It develops and manufactures innovative handheld launchers and projectiles designed for self-defense, law enforcement, and private security use.
Read more on BYRN →